Css LLC Organon & Co. Transaction History

Css LLC

$999 Million
Q3 2024

A detailed history of Css LLC transactions in Organon & Co. stock. As of the latest transaction made, Css LLC holds 54,745 shares of OGN stock, worth $798,182. This represents 0.1% of its overall portfolio holdings.

Number of Shares

54,745

Previous 36,000 52.07%

Holding current value

$798,182

Previous $745,000 40.54%

% of portfolio

0.1%

Previous 0.07%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$18.65 - $23.03 $349,594 - $431,697	18,745 Added 52.07%	54,745 $1.05 Million
Q2 2024 Aug 14, 2024	BUY	$17.45 - $21.96 $209,400 - $263,520	12,000 Added 50.0%	36,000 $745,000
Q1 2024 May 15, 2024	BUY	$13.78 - $18.8 $55,120 - $75,200	4,000 Added 20.0%	24,000 $451,000
Q4 2023 Feb 14, 2024	SELL	$10.95 - $17.32 $98,550 - $155,880	-9,000 Reduced 31.03%	20,000 $288,000
Q3 2023 Nov 14, 2023	SELL	$16.59 - $23.77 $33,180 - $47,540	-2,000 Reduced 6.45%	29,000 $503,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $385,400 - $492,600	20,000 Added 181.82%	31,000 $645,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $171,360 - $256,640	-8,000 Reduced 42.11%	11,000 $258,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $268,065 - $329,015	-11,500 Reduced 37.7%	19,000 $530,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $409,500 - $599,375	17,500 Added 134.62%	30,500 $714,000
Q2 2022 Aug 15, 2022	BUY	$31.66 - $38.9 $411,580 - $505,700	13,000 New	13,000 $439,000
Q1 2022 May 16, 2022	SELL	$30.45 - $39.36 $384,888 - $497,510	-12,640 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$28.45 - $38.0 $359,608 - $480,320	12,640 New	12,640 $383,000

Others Institutions Holding OGN

# of Institutions

793

Shares Held

192M

Call Options Held

1.71M

Put Options Held

865K

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.71B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Account